These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10366018)

  • 21. The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat.
    Petrie KA; Bubser M; Casey CD; Davis MD; Roth BL; Deutch AY
    Neuropsychopharmacology; 2004 Oct; 29(10):1878-88. PubMed ID: 15150532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
    Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
    Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
    Tanda G; Loddo P; Di Chiara G
    Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis.
    Wagstaff JD; Gibb JW; Hanson GR
    Brain Res; 1996 May; 721(1-2):196-203. PubMed ID: 8793101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability.
    Crunelle CL; van de Giessen E; Schulz S; Vanderschuren LJ; de Bruin K; van den Brink W; Booij J
    Addict Biol; 2013 Nov; 18(6):908-11. PubMed ID: 21955259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
    Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
    Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
    Fujimura M; Hashimoto K; Yamagami K
    Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.
    Robertson GS; Jian M
    Neuroscience; 1995 Feb; 64(4):1019-34. PubMed ID: 7753373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.
    Pinna A; Wardas J; Cozzolino A; Morelli M
    Neuropsychopharmacology; 1999 Jan; 20(1):44-51. PubMed ID: 9885784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex.
    Brooks JM; Sarter M; Bruno JP
    Neuropharmacology; 2007 Sep; 53(3):455-63. PubMed ID: 17681559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    Midgley LP; Wagstaff JD; Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1994 Jan; 251(2-3):191-9. PubMed ID: 7908639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burst stimulation of the medial forebrain bundle selectively increase Fos-like immunoreactivity in the limbic forebrain of the rat.
    Chergui K; Nomikos GG; Mathé JM; Gonon F; Svensson TH
    Neuroscience; 1996 May; 72(1):141-56. PubMed ID: 8730713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats.
    Sun W; Rebec GV
    Psychopharmacology (Berl); 2005 Jan; 177(3):315-23. PubMed ID: 15309375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.
    Perreault ML; Shen MY; Fan T; George SR
    Neuroscience; 2015 Jan; 285():194-203. PubMed ID: 25446350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.
    Alburges ME; Hoonakker AJ; Hanson GR
    Eur J Pharmacol; 2007 Nov; 573(1-3):124-32. PubMed ID: 17689525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.